Abstract
Objective
To study the clinico-etiological spectrum and outcomes of children with rapidly progressive glomerulonephritis (RPGN).
Methods
This retrospective cohort study evaluated patients <18 years with RPGN, over an 8-year period (2014–2022), for etiology and kidney outcomes.
Results
Among 68 RPGN cases [median age 10 (7,12) years], 23 (33.8%) had lupus nephritis, 21 (30.9%) C3 glomerulopathy, and 15 (22.1%) infection-related glomerulonephritis (IRGN). At presen-tation, 18 (26.4%) patients had pulmonary edema, 20 (29.4%) had hypertensive emergency and 22 (32.4%) required dialysis. Median (IQR) follow-up duration was 24.5 (12,48) months. The median (IQR) admission eGFR was 19 (10.93, 38.60) mL/min/1.73 m2, which increased to 126 (102.7,142) mL/min/1.73m2 at the last follow-up. At the last follow-up, 39 (57.3%) and 13 (19.1%) patients attained complete and partial renal recovery, respectively; while 16 (23.5%) progressed to CKD stage 2 and beyond. The prevalence of end stage kidney disease (ESKD) was 7.3% at 1-year and 7.7% at the last follow-up. Factors predicting kidney survival were duration of symptoms prior to presentation ≥7 days, crescents ≥37.5%, and presence of fibrous crescents/segmental sclerosis.
Conclusion
Lupus nephritis, was the commonest etiology of RPGN in children. Renal outcomes were determined by pre-admission symptoms, and percentage and stage of crescents.
References
Trimarchi H. Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective. Pediatr Nephrol. 2022;37:1205–14.
Maliakkal JG, Hicks MJ, Michael M, et al. Renal survival in children with glomerulonephritis with crescents: A pediatric nephrology research consortium cohort study. J Clin Med. 2020;9:2385.
The Southwest Pediatric Nephrology Study Group. A clinicopathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int. 1985;27:450–58.
Mayer U, Schmitz J, Brasen JH, Pape L. Crescentic glomerulonephritis in children. Pediatr. Nephrol. 2020;35: 829–42.
Jardim HM, Leake J, Risdon RA, Barratt TM, Dillon MJ. Crescentic glomerulonephritis in children. Pediatr. Nephrol. 1992;6:231–35.
Srivastava RN, Moudgil A, Bagga A, et al. Crescentic glomerulonephritis in children: A review of 43 cases. Am. J. Nephrol. 1992;12:155–61.
Sinha A, Puri K, Hari P, et al. Etiology and outcome of crescentic glomerulonephritis. Indian Pediatr. 2013;50:283–88.
Dewan D, Gulati S, Sharma RK, et al. Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries. Pediatr Nephrol. 2008;23:389–94.
Ozlu SG, Caltik A, Aydog O, et al. Crescentic glomerulonephritis in children: A single centre experience. World J Pediatr. 2016;12:225–30.
Koyama A, Yamagata K, Makino H, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: Etiology, prognosis and treatment diversity. Clin. Exp. Nephrol. 2009;13:633–50.
Rampelli SK, Rajesh NG, Srinivas BH, et al. Clinical spectrum and outcomes of crescentic glomerulonephritis: A single center experience. Indian J Nephrol. 2016;26:252–6.
Gupta R, Singh L, Sharma A, et al. Crescentic glomerulonephritis: A clinical and histomorphological analysis of 46 cases. Indian J Pathol Microbiol. 2011;54:497–500.
Alsaad, K, Oudah N, Al Ameer A, et al. Glomerulonephritis with crescents in children: Etiology and predictors of renal outcome. ISRN Pediatr. 2011;2011:507298.
Vijayakumar M. Acute and crescentic glomerulonephritis. Indian J Pediatr. 2002;69:1071–75.
Sinha A, Bagga A, Banerjee S, et al. Expert Group of Indian Society of Pediatric Nephrology. Steroid Sensitive Nephrotic Syndrome: Revised Guidelines. Indian Pediatr. 2021;58: 461–81.
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140:e20171904.
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58: 259–63.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2: 1–138.
Haas M, Seshan SV, Barisoni L, et al. Consensus Definitions for Glomerular Lesions by Light and Electron Microscopy: Recommendations From a Working Group of the Renal Pathology Society. Kidney Int. 2020;98:1120–34.
Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: Clarification of Definitions, and Modified National Institutes of Health Activity and Chronicity Indices. Kidney Int. 2018;93:789–96.
Weening JJ, D’Agati VD, Schwartz MM, et al. International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited. Kidney Int. 2004;65:521–30.
Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–41.
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;S115–S193.
Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013; 368:2402–14
Leung AKC, Barankin B, Leong KF. Henoch-Schönlein purpura in children: An updated review. Curr Pediatr Rev. 2020;16:265–76.
Pickering MC, D’Agati VD, Nester CM, et al. C3 glomerulopathy: consensus report. Kidney Int. 2013;84:1079–89.
Gunasekaran K, Krishnamurthy S, Mahadevan S, et al. Clinical characteristics and outcome of post-infectious glomerulonephritis in children in southern India: A prospective study. Indian J Pediatr. 2015;82:896–903.
Patel P, de Guzman M, Hicks MJ, et al. Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: A Pediatric Nephrology Research Consortium study. Pediatr Nephrol. 2022;37: 3139–45.
Funding
Funding: None
Author information
Authors and Affiliations
Contributions
Contributors: BD, SK, AM, PK, SuK: managed the patients. BD conceptualized the study design and participated in study protocol preparations, recruited patients, participated in data analysis, and drafted the first version of the manuscript. SK conceptualized the study design and critically revised the manuscript. RNG interpreted the histopathology findings. SG helped in statistical analysis. All authors contributed to drafting of the manuscript and approved the final version.
Corresponding author
Ethics declarations
Ethics approval: Approved by the Ethics Committee of the institute; No. JIP/IEC/2022/0117 dated May 11, 2022.
Competing interests: None stated.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Deepthi, B., Krishnamurthy, S., Ganesh, R.N. et al. Etiology and Outcomes of Rapidly Progressive Glomerulonephritis in Children: A Retrospective Cohort Study. Indian Pediatr 60, 816–821 (2023). https://doi.org/10.1007/s13312-023-3011-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-023-3011-1